Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 9;25(1):2718.
doi: 10.1186/s12889-025-24073-5.

Evaluating Jordan's antimicrobial resistance national action plan (2018-2022) implementation: progress and recommendations

Salam Momani  1 , Mohammad S Alyahya  2   3 , Dalia K Zayed  2 , Ala Bin Tarif  2 , Omar F Nimri  2 , Sami Alshaikh  2 , Adel Belbiesi  2 , Ala'a B Al-Tammemi  2
Affiliations

Evaluating Jordan's antimicrobial resistance national action plan (2018-2022) implementation: progress and recommendations

Salam Momani et al. BMC Public Health. .

Abstract

Background: Antimicrobial resistance (AMR) is a pressing global public health challenge that requires coordinated multi-sectoral responses under the One Health framework. In line with the Global Action Plan (GAP) on AMR, Jordan developed its first National Action Plan (NAP) for 2018-2022 to guide national efforts. This study aimed to evaluate the implementation of Jordan's AMR NAP 2018-2022, identify progress and challenges across its five strategic objectives, and suggest actionable recommendations for strengthening future AMR responses.

Methods: A comprehensive end-term evaluation was conducted for the NAP 2018-2022 by the Jordan Center for Disease Control (Jordan CDC), utilizing a structured evaluation tool including sector-specific and multi-sectoral indicators aligned with the five objectives of the AMR NAP. Data were collected via national stakeholder workshop and follow-up electronic communications, with consensus-based completion by multi-sectoral working groups. Descriptive analysis was used to assess implementation across human, animal, food and environmental sectors, applying the One Health approach.

Results: The evaluation revealed uneven implementation across sectors and NAP objectives, with notable achievements in the rational use of antimicrobials (69%), mainly in the human health sector, followed by infection prevention and control (IPC) efforts (63%), and surveillance-related activities (56%). Lower progress was reported for awareness activities (47%), while research and innovation activities were not implemented during 2018-2022. Although human health sector activities dominated, gaps persisted across the animal, food, and environmental sectors. Limited intersectoral coordination, the absence of a unified communication strategy, lack of dedicated funding, insufficient investment in human resources and laboratories, and the disruptions caused by the Coronavirus Disease 2019 (COVID-19) pandemic further constrained implementation. The findings underscore critical gaps in One Health surveillance integration, rational antimicrobial use in the food chain, and the need for robust AMR research governance.

Conclusions: Despite progress in different areas, the overall implementation revealed significant challenges, particularly in research, multi-sectoral collaboration, and the One Health integration. Future action should prioritize a unified national AMR policy framework for strategic planning, emphasizing resource distribution, active participation of all relevant sectors, and institutionalizing systematic monitoring and evaluation to inform policymaking. Strengthening coordination between human, animal, and environmental sectors is essential to achieving a robust, One Health-aligned AMR response in Jordan.

Keywords: Antimicrobial resistance; Antimicrobial stewardship; Jordan; Monitoring and evaluation; National action plan; One health; Public health policy; Rational consumption; Surveillance.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study was conducted under the auspices of the Jordan Center for Disease Control (Jordan CDC), a national governmental authority for public health. The Research, Health Policy, and Training Directorate at Jordan CDC reviewed the study protocol and concluded that formal ethical approval was not required. This determination was based on the study’s nature, which involved no experimentation or direct interaction with patients or human subjects and relied solely on secondary data analysis and stakeholder input. Accordingly, the study was granted an exemption from full IRB review. Informed consent was obtained from all experts who contributed their insights and feedback. Expert input was solicited from relevant institutions to ensure the credibility and rigor of the findings. The study did not involve human or animal subjects, and all procedures adhered to the ethical principles outlined in the Declaration of Helsinki (1964) and its subsequent amendments. Consent for publication: Not Applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Methodology flowchart
See this image and copyright information in PMC

References

    1. Majumder MAA, Rahman S, Cohall D, Bharatha A, Singh K, Haque M, Gittens-St Hilaire M. Antimicrobial stewardship: fighting antimicrobial resistance and protecting global public health. Infect Drug Resist. 2020;13:4713–38. - PMC - PubMed
    1. Capozzi C, Maurici M, Panà A. Antimicrobial resistance: it is a global crisis, a slow tsunami. Ig Sanita Pubbl. 2019;75(6):429–50. - PubMed
    1. Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist 2019:3903–10. - PMC - PubMed
    1. Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, Alqumber MA. Antimicrobial resistance: a growing serious threat for global public health. In: Healthcare: 2023: MDPI; 2023: 1946. - PMC - PubMed
    1. Hernando-Amado S, Coque TM, Baquero F, Martínez JL. Defining and combating antibiotic resistance from one health and global health perspectives. Nat Microbiol. 2019;4(9):1432–42. - PubMed